Zrc Wealth Management, LLC Akero Therapeutics, Inc. Transaction History
Zrc Wealth Management, LLC
- $237 Billion
- Q4 2024
A detailed history of Zrc Wealth Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Zrc Wealth Management, LLC holds 60 shares of AKRO stock, worth $2,976. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 60
-0.0%
Holding current value
$2,976
Previous $1.72 Million
3.02%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$366 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$340 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$299 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$277 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$260 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.3B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...